Get started
Author

John Hoekman

Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke
2009 · Leah R. Hanson, Annina Roeytenberg, et al. · Journal of Pharmacology and Experimental Therapeutics · 224
PDF
Dihydroergotamine (DHE) – Then and Now: A Narrative Review
2019 · Stephen D. Silberstein, Stephen B. Shrewsbury, et al. · Headache The Journal of Head and Face Pain · 76
PDF
Enhanced Analgesic Responses After Preferential Delivery of Morphine and Fentanyl to the Olfactory Epithelium in Rats
2011 · John D. Hoekman, Rodney J. Y. Ho · Anesthesia & Analgesia · 62
Novel Gd Nanoparticles Enhance Vascular Contrast for High-Resolution Magnetic Resonance Imaging
2010 · Tot Bui, Jeff Stevenson, et al. · PLoS ONE · 57
PDF
Effects of Localized Hydrophilic Mannitol and Hydrophobic Nelfinavir Administration Targeted to Olfactory Epithelium on Brain Distribution
2011 · John Douglas Hoekman, Rodney J. Y. Ho · AAPS PharmSciTech · 53
PDF
Nasal Delivery of Acute Medications for Migraine: The Upper Versus Lower Nasal Space
2021 · Vincent Martin, John Hoekman, et al. · Journal of Clinical Medicine · 45
PDF
STOP 101: A Phase 1, Randomized, Open‐Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD ® ) Device, in Healthy Adult Subjects
2019 · Stephen B. Shrewsbury, Maria Jeleva, et al. · Headache The Journal of Head and Face Pain · 37
PDF
Intranasal delivery of growth differentiation factor 5 to the central nervous system
2012 · Leah R. Hanson, Jared M. Fine, et al. · Drug Delivery · 32
PDF
Identification of mouse brain proteins associated with isoform 3 of metallothionein
2005 · David W. Lahti, John D. Hoekman, et al. · Protein Science · 31
PDF
Positron Emission Tomography Assessment of the Intranasal Delivery Route for Orexin A
2017 · Genevieve C. Van de Bittner, Kyle C. Van de Bittner, et al. · ACS Chemical Neuroscience · 30
Aerosol-Stable Peptide-Coated Liposome Nanoparticles: A Proof-of-Concept Study with Opioid Fentanyl in Enhancing Analgesic Effects and Reducing Plasma Drug Exposure
2014 · John D. Hoekman, Pramod Srivastava, et al. · Journal of Pharmaceutical Sciences · 28
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action
2022 · Wade Cooper, Sutapa Ray, et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 23
The SNAP 101 Double-Blind, Placebo/Active-Controlled, Safety, Pharmacokinetic, and Pharmacodynamic Study of INP105 (Nasal Olanzapine) in Healthy Adults
2020 · Stephen B. Shrewsbury, Jasna Hocevar-Trnka, et al. · The Journal of Clinical Psychiatry · 21
PDF
The Upper Nasal Space—A Novel Delivery Route Ideal for Central Nervous System Drugs
2020 · John Hoekman, Sutapa Ray, et al. · touchREVIEWS in Neurology · 17
PDF
Intranasal Tat Alters Gene Expression in the Mouse Brain
2007 · Lynn Pulliam, Bing Sun, et al. · Journal of Neuroimmune Pharmacology · 14
The Pharmacokinetics of Drug Delivery to the Upper Nasal Space: A Review of INP105 Development
2022 · Stephen Bevan Shrewsbury, Greg Davies, et al. · Medical Research Archives · 5
PDF
Cardiovascular Safety Results of INP104 (POD-DHE) from the STOP 301 Phase 3 Study (2493)
2021 · Karen Craig, John Hoekman, et al. · Neurology · 4
A long-term, open label Safety and Tolerability Study Of Precision Olfactory Delivery of DHE in Acute Migraine Treatment (STOP 301): Exploratory Efficacy Results (2490)
2021 · Sheena Aurora, Timothy Smith, et al. · Neurology · 2
DHE Pharmacology Revisited: Does a broad receptor profile molecule treat the whole migraine? (2496)
2021 · Sheena K. Aurora, Sutapa Ray, et al. · Neurology · 2
Development of a Precision Olfactory Delivery (POD®)-Olanzapine Drug-Device Product for Agitation
2019 · Kelsey Satterly, Bhavin Gajera, et al. · eScholarship (California Digital Library) · 2
PDF
Molecular Modeling of the Calmodulin Binding Region of Calcineurin
2006 · John D. Hoekman, Abigail M. Tokheim, et al. · The Protein Journal · 2
Placebo/Active Controlled, Safety, Pharmaco-Kinetic/Dynamic Study of INP105 (POD® olanzapine) in Healthy Adults
2019 · SB Shrewsbury, Meghan Swardstrom, et al. · eScholarship (California Digital Library) · 1
PDF
Intranasal Delivery of Insulin–Like Growth Factor–1 Distributes to the Optic Nerve and Retina in the Rat
2006 · Sandra R. Alcala, N. Danylkova, et al. · Investigative Ophthalmology & Visual Science · 1
A Novel Sirna-Based Insulin Sensitizer, Jun 01, Targeting the Integrated Stress Response in Diabetic Mice
2025 · John Hoekman, Charu Reddy, et al. · Metabolism
Patient acceptability of INP104 aligns with the unmet needs identified in I-BEAM survey. (2498)
2021 · Stephen Shrewsbury, Sheena K. Aurora, et al. · Neurology
Works count: 30
Citation count: 769
H-index: 14
I10-index: 15
Year
Topic
Type